Brian Rini, MD Professor of Medicine from Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center speaks about AVEO Oncology Announces U.S. FDA Approval of FOTIVDA® (tivozanib) for the Treatment of Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma. Link to Press Release:https://investor.aveooncology.com/news-releases/news-release-details/aveo-oncology-announces-us-fda-approval-fotivdar-tivozanib FOTIVDA was approved based on the results of AVEO’s pivotal Phase 3 … Continue reading Brian Rini, MD @brian_rini @VUMC_Cancer #TIVO3 #KidneyCancer #Cancer #Research U.S. FDA Approval tivozanib for the Treatment of Adult Pts with RARCC